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Original article
Purpose: Acanthosis nigricans (AN) is a hyperpigmented dermatosis associated with 
obesity and insulin resistance (IR). There is no consensus whether AN extension 
scoring offers added value to the clinical estimation of IR. In this study we aimed 
to assess and score AN using both a short and an extended version of the scale 
proposed by Burke et al. and analyze the relationships of both versions with hyper­
insulinemia and IR.
Methods: We analyzed data from 139 overweight adolescents (body mass index 
≥85th percentile) aged 12–18 with (n=67) or without (n=72) AN who were followed 
at a pediatric obesity clinic. 
Results: Adolescents with AN had higher levels of insulin (d=0.56, P=0.003) and 
HOMA­IR (d=0.55, P=0.003) compared to those without. Neither the short nor the 
extended versions of AN scores explained either hyperinsulinemia (β=1.10, P=0.316; 
β=1.15, P=0.251) or IR (β=1.07, P=0.422; β=1.10, P=0.374). The presence of AN alone 
predicted hyperinsulinemia and the presence of IR in 7.3% (β=2.68, P=0.008) and 
7.1% (β=2.59, P=0.009) of adolescents, respectively.
Conclusion: Screening for AN at the neck and axilla is a noninvasive and cost­
effective way to identify asymptomatic overweight adolescents with or at risk of 
developing IR.
Keywords: Adolescents, Acanthosis nigricans, Overweight, Hyperinsulinemia, Insulin 
resistance
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Introduction
Obesity is a major public health concern, associated with high cardiovascular and 
metabolic risks1,2) and often leading to premature death in adulthood.3) Among the metabolic 
comorbidities, hyperinsulinemia and/or insulin resistance (IR) are of particular interest due to 
the alarming increase of type 2 diabetes in youth.4) 
Acanthosis nigricans (AN) is a dermatological condition consisting of symmetrical 
hyperpigmentation and thickened skin with a rough, velvety texture. AN is typically 
asymptomatic, although it can sometimes be pruritic. It may affect any part of the skin, but is 
most common in regions affected by friction. Common sites therefore include the neck, axilla, 
elbows, knuckles, knees, groin, and anogenital areas.5-7) Although the pathogenesis of AN is 
not fully known, the underlying mechanism is the interaction between insulin-like growth 
factor 1 (IGF-1) and IGF binding protein 1 (IGFBP-1), which is associated with high insulin 
levels. Hyperinsulinemia may inhibit IGFBP-1 synthesis and increase the synthesis of IGF-1 in 
the liver. The increase in IGF-1 circulating concentrations and IGF-1 receptor activation may 
trigger dermal fibroblast and epidermal keratinocyte proliferation.5-8) 
During puberty adolescents have hyperinsulinemic physiological status.9) Even higher 
levels of insulin are observed among overweight adolescents due to increased adipose 
tissue, associated with increased plasma free fatty acids and adipokines, which in turn may 
Acanthosis nigricans as a clinical marker of insulin 
resistance among overweight adolescents
Antonio Videira­Silva, MSc1, 
Carolina Albuquerque, MD, 
MSc2, Helena Fonseca, MD, 
MPH, PhD3,4
1Pediatric University Clinic, Faculty of 
Medicine, University of Lisbon, Lisbon, 
Portugal
2Department of Pediatrics, Hospital 
Vila Franca de Xira, Vila Franca de Xira, 
Portugal
3Pediatric Obesity Clinic, Department 
of Pediatrics, Hospital de Santa Maria, 
Lisbon, Portugal
4Rheumatology Research Unit, Mole­
cular Medicine Institute, Faculty of 
Medicine, University of Lisbon, Lisbon, 
Portugal
Received: 8 August, 2018
Revised: 11 October, 2018
Accepted: 9 November, 2018 
Address for correspondence: 
António Videira­Silva, MSc
Pediatric University Clinic, Faculty of 
Medicine, University of Lisbon, Av. 
Prof. Egas Moniz, 1649­035, Lisbon, 
Portugal
Tel: +351969172368
Fax: +351217985100
E­mail: antonioascenso@campus.
ul.pt
https://orcid.org/0000­0002­8209­
1676
https://doi.org/10.6065/apem.2019.24.2.99
Ann Pediatr Endocrinol Metab 2019;24:99­103
Videira-Silva A, et al. • Acanthosis nigricans as a clinical marker of insulin resistance
100 www.e-apem.org
impair glucose transport activity, resulting in IR. IGF-1 may 
play an important role in this relationship. IGF-I binds to 
insulin receptors, stimulating glucose transport in the adipose 
and muscle tissues, inhibiting hepatic glucose output, and 
simultaneously suppressing insulin secretion, which may lead 
to a decrease in blood glucose.10) However, in the presence of 
IR and consequent hyperinsulinemia, lower levels of IGFBP-1 
may lead to disturbances in glucose homeostasis and possibly 
to prolonged states of IR. These factors may explain the higher 
prevalence of AN among overweight adolescents, compared to 
adults and adolescent peers who are not overweight.11) 
In addition, several previous studies have reported higher 
AN prevalence among Black adolescents, associated with 
insulin hyper-secretion and IR, compared to their White 
peers.12) Although it is not fully understood whether insulin 
hyper-secretion/IR are associated with genetic, lifestyle, and/
or socioeconomic differences,13) there is a consensus that AN is 
associated with overweight and IR.
Although several authors have suggested that the presence of 
AN may be used as a clinical marker for hyperinsulinemia and 
IR in overweight adolescents, there is no consensus whether AN 
scoring adds value to the clinical estimation of IR.14,15) Burke's 
scale is the most widespread measure used to score AN.15) Two 
different versions of this scale (a short and an extended version) 
are used inconsistently across studies. In addition to this 
limitation, most previous studies used unbalanced group sizes 
for comparisons, which may have biased their conclusions.
The main aim of this study was to assess and score AN, using 
a short (neck and axilla) and an extended version (neck, axilla, 
elbows, knuckles and knees) of the scale proposed by Burke at 
al.,15) and to analyze the predictive power of both versions for 
the clinical estimation of IR.
Materials and methods
1. Participants
For this cross-sectional study, we analyzed data from a 
sample of overweight adolescents (body mass index [BMI] 
≥85th percentile) aged between 12 and 18 years old who were 
undergoing treatment at a pediatric obesity clinic.
A total of 79 adolescents were screened for AN between July 
2015 and December 2016. Of these, 67 (84.8%) were scored 
according to Burke's scale.15) Since unbalanced sample sizes can 
result in inaccurate statistical outcomes and may influence type 
I error rates,16) we added independent data for 60 adolescents 
who attended the clinic during the 18-month period 
immedia tely prior to July 2015 to the without-AN group (12, 
corresponding to 15.2%), for a total of 72 adolescents. Clinical 
data for these adolescents were collected retrospectively. The 
recruitment design is presented in Fig. 1.
None of  the included participants met the criteria for 
diabetes, nor did any present with other clinical conditions or 
report using medication that could promote hyperinsulinemia 
or AN development. 
2. Measurements
1) Anthropometric and body composition assessments
Height was assessed with a height stadiometer (seca 217, seca 
GmbH & Co. KG, Hamburg, Germany) with the head in the 
Frankfort plane, without shoes, with the participant's back to the 
stadiometer, and after an expiratory phase. Height was registered 
to the nearest 0.1 cm.
Body weight and body composition were measured with 
a bioelectrical impedance scale (InBody 230, InBody, Seoul, 
Korea) to the nearest 0.1 kg, with the subjects wearing as few 
clothes as possible, and without shoes or socks. Relative body fat 
mass (%BFM) and relative skeletal muscle mass (%SMM) were 
calculated by dividing the total BFM (kg) and SMM (kg) by 
body weight, respectively.
BMI was calculated by dividing the body weight in kilograms 
by the square of height in meters [BMI=weight (kg)/height2 (m)]. 
The calculation of BMI z-score was based on World Health 
Organization data [BMI z-score=[(BMI/M(t))L(t)-1]/L(t)S(t)]. 
Waist (WC) and hip circumferences (HipC) were assessed 
using a flexible anthropometric tape (seca 203). WC was 
measured at the level of the iliac crest, with the subjects standing 
and at the end of a regular expiration (Cameron method), and 
HipC at the maximum protuberance of the buttocks.
2) Clinical assessments
Pubertal status was assessed and categorized according to 
Tanner stages. AN was assessed by the same investigator and 
scored according to the scale outlined by Burke et al.15) Two 
different scores were calculated: AN score 1 and AN score 2. AN 
score 1 was calculated as the sum of the scores in each of the 
most prevalent AN locations (i.e., neck, axilla) and texture [AN 
score 1= neck score (0–4) + axilla score (0–4) + texture (0–3)]. 
AN score 2 was calculated as AN score1, plus the presence (or 
absence) of AN at the elbows, knuckles, and/or knees [AN score 
2=neck score (0–4) + axilla score (0–4) + texture (0–3) + elbows 
(0–1) + knuckles (0–1) + knees (0–1)] (Supplemental Table 1).
January 2014
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Fig. 1. Recruitment design. AN, acanthosis nigricans.
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Resting blood pressure was measured using a digital 
sphygmomanometer (CAS 9302S, CAS Medical Systems, 
Branford, CT, USA) in the right arm with an appropriate 
size cuff, after five minutes of rest in the seated position. The 
measurement was performed three times and the average of the 
three measurements was recorded.
Biochemical analysis was performed in the laboratory of 
Clinical Pathology at the hospital. Blood samples were collected 
after overnight fasting (12 hours) in the presence of one of 
the parents/caregivers, and after local application of a topical 
anesthesia patch (eutectic mixture of local anesthetics, EMLA). 
Blood glucose levels were determined using the hexokinase 
method, and insulin was assessed using a chemiluminescence 
immunoassay technique (ADVIA 2400, Siemens, Newark, DE, 
USA). IR was derived by the homeostasis model assessment 
(HOMA-IR) method, as follows: insulin (μUI/mL)×glucose 
(mg/dL/405). Insulin and HOMA-IR values ≥90th percentile 
were considered to represent hyperinsulinemia and IR, 
respectively.17,18) (Supplemental Table 2).
3. Statistical analysis
Data were analyzed using IBM SPSS Statistics ver. 22.0 (IBM 
Co., Armonk, NY, USA).
Chi-square tests and independent sample t-tests were used to 
analyze differences between the without-AN and AN groups. 
Logistic regression analyses were conducted to analyze the 
influence of AN severity scores on IR and hyperinsulinemia. 
A P-value of <0.05 was considered statistically significant and 
odds values >1.5 as the minimum acceptable effect size.
Results
Data from 139 overweight adolescents (45.3% girls, 5.2% 
Black), with a mean age of 14.4 (±1.8) years and mean BMI 
z-score 2.50 (±1.1), were included in the analysis. There was 
no significant difference in the number of Black adolescents 
between the AN and without-AN groups (7.5 vs. 2.8%, P=0.207).
The neck was the most prevalent AN location (85.1%), 
followed by the axilla (74.6%), elbows (38.8%), knuckles (23.9%), 
and knees (20.9%) (Table 1). All participants with AN at the 
elbows, knuckles, and/or knees also had AN at the neck and/or 
axilla, but not vice-versa (data not shown).
Adolescents with AN (n=67) showed higher levels of insulin 
(d=0.56, P=0.003) and HOMA-IR (d=0.55, P=0.003), and higher 
prevalence of hyperinsulinemia (70.2% vs. 47.2%, P=0.008) 
and IR (62.7% vs. 38.9%, P=0.008), compared to adolescents 
without AN (n=72) (Table 1). In addition, insulin and HOMA-
IR levels tended to be higher among adolescents with AN and 
IR, compared to adolescents without AN but with IR (d=0.45, 
P=0.065; d=0.44, P=0.067) (data not shown).
None of the AN severity scores was able to explain either 
hyperinsulinemia (β=1.10, P=0.316; β=1.15, P=0.251) or IR 
Table 1. Clinical characteristics of the participants
Characteristic AN group(n=67)
Without-AN group
(n=72) P-value
Sex, girls 32 (47.8) 31 (43.1) 0.578a)
Race, Black 5 (7.5) 2 (2.8) 0.207a)
Age (mo) 176±19 170±22 0.117
Tanner stage 0.004a)
  I 0 (0) 1 (1.4)
  II 1 (1.5) 14 (19.4)
  III 12 (17.9) 12 (16.7)
  IV 17 (25.4) 21 (29.2)
  V 37 (55.2) 24 (33.3)
BMI z-score 2.51±1.34 2.49±0.87 0.893
WC (cm) 102.4±14.2 99.4±12.8 0.230
BFM (%) 41.2±6.1 40.3±5.6 0.461
SMM (%) 32.4±6.1 33.9±5.5 0.129
SBP (mmHg) 123.1±12.9 119.0±12.6 0.060
DBP (mmHg) 62.8±9.5 61.1±10.5 0.337
Glycemia (mg/dL) 84.6±8.2 84.1±6.5 0.693
Insulin (μlU/mL) 26.4±16.3 19.0±10.3 0.003
HOMA-IR 5.59±3.51 4.00±2.29 0.003
Total cholesterol (mg/dL) 159.5±27.7 152.8±28.0 0.169
HDL-C (mg/dL) 47.2±11.3 50.8±12.7 0.084
Triglycerides (mg/dL) 94.5±55.1 79.0±39.3 0.064
Hyperinsulinemia
  (≥90th percentile)
47 (70.2) 34 (47.2) 0.008a)
IR
  (HOMA-IR ≥90th percentile)
42 (62.7) 28 (38.9) 0.008a)
AN neck 57 (85.1) - -
AN axilla 50 (74.6) - -
AN elbows 26 (38.8) - -
AN knuckles 16 (23.9) - -
AN knees 14 (20.9) - -
Values are presented as number (%) or mean±standard deviation.
BMI, body mass index; WC, waist circumference; BFM, body fat 
mass; SMM, skeletal muscle mass; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; HOMA­IR, homeostatic model 
assessment­insulin resistance; HDL­C, high­density lipoprotein 
cholesterol; AN, acanthosis nigricans.
a)Chi­square test.
Table 2. Summary of logistic regression analysis for AN e AN severity scores for the prediction of hyperinsulinemia and insulin resistance 
Hyperinsulinemia IR
β SE OR P-value Sensitivity Specificity β SE OR P-value Sensitivity Specificity
AN score 1 0.091 0.091 1.10 0.316 0.065 0.081 1.07 0.422
AN score 2 0.141 0.123 1.15 0.251 0.097 1.09 1.10 0.374
AN (presence) 0.987 0.374 2.68 0.008 66.0% 58.0% 0.952 0.362 2.59 0.009 63.3% 60.0%
AN, acanthosis nigricans; IR, insulin resistance; β, unstandardized beta; OR, odds ratio; SE, standard error for the unstandardized beta.
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(β=1.07, P=0.422; β=1.10, P=0.374). However, the presence of 
AN alone predicted hyperinsulinemia and the presence of IR in 
7.3% (β=2.68, P=0.008) and 7.1% (β=2.59, P=0.009) of subjects, 
respectively. Adolescents with AN had 2.59 and 2.68 greater 
odds of having hyperinsulinemia or IR, respectively, compared 
to those without AN (Table 2). 
Discussion
A review of the literature suggests that AN is a clinical marker 
for hyperinsulinemia and IR in overweight adolescents.19) 
Although one could expect that more severe AN would be 
associated with more severe IR, there is no consensus in this 
regard.15,20,21) Results indicating the relevance of AN scoring 
for the prediction of IR severity may be biased by inconsistent 
application of the scoring system and unbalanced sample sizes. 
In order to overcome these limitations, we opted to use both 
versions of the AN scale proposed by Burke et al.15) and to 
ensure balanced sample sizes. 
Our findings suggest that AN scoring is not useful for the 
estimation of hyperinsulinemia or IR. However, the presence of 
AN alone predicted hyperinsulinemia and the presence of IR in 
7.3% and 7.1% of subjects, with sensitivities of 66.0% and 63.3%, 
respectively.
AN is a dermatological condition triggered by high insulin 
levels, usually as a consequence of IR status.6-8) We postulate 
that AN is an ongoing process sensitive not only to insulin level 
variation, but also to the duration of IR status. Persistent/chronic 
high insulin levels may induce dermal fibroblasts and epidermal 
keratinocyte proliferation, AN development, and increased AN 
severity/extension. However, high AN severity may occur in the 
presence of high insulin levels during a shorter time frame of 
exposure.
About 63% of the adolescents in the AN group exhibited IR. 
It is possible that the remaining 37% developed IR at a specific 
point in time, with ulterior reversion, and consequent insulin 
level normalization, leading to reduction of the AN extent 
overtime, but not to its complete reversion.5,6,22,23) On the other 
hand, the 39% of adolescents without AN with IR could have 
developed IR more recently, and/or their insulin levels were not 
high enough to trigger AN development. Indeed, despite IR, 
adolescents without AN have lower levels of insulin, compared 
to those with AN.
This balance between time of exposure to high insulin levels 
and the severity of hyperinsulinemia may explain the non-linear 
relationship observed between insulin/HOMA-IR and AN 
severity score. In order to understand this relationship, further 
longitudinal studies are needed.
Although the difference was not statistically significant, it is 
interesting to observe that the number of Black adolescents was 
higher in the AN group, which is in line with the results reported 
by previous studies.12) Nevertheless, because the difference in 
the number of Black adolescents between the AN and without-
AN groups was not statistically significant, we hypothesized that 
the effects on the results were also not significant.
This study has some limitations. One is the cross-sectional 
design, which does not allow for causal inferences. Another 
possible limitation is the addition of data from 60 adolescents 
without AN, which were retrospectively collected. Although 
this addition may result in bias, the reason for the use of 
retrospective data was to balance the sample size, to address one 
of the main concerns of this study. In addition, all retrospective 
data were collected by the same healthcare professionals.
Despite the acknowledged limitations, the results of this study 
suggest that the neck and axilla should be routinely assessed for 
the presence of AN, since it is a noninvasive and cost-effective 
way to identify asymptomatic overweight adolescents who have 
or are at risk of developing IR, which can be  associated with 
early development of type 2 diabetes mellitus.19,24)
Since AN may have a strong visual impact, its presence 
alone may be a strong reason for seeking medical care during 
adolescence. In addition, due to the psychological distress that 
it may cause,25) AN can be used as a motivational trigger for 
lifestyle changes and weight loss, through the enhancement of 
diet and physical exercise. 
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